Facebook
Twitter
Telegram
Fehler meldenAdaptimmune Therapeutics plc Bilanz 2011-2024 | ADAP
Bilanz Jährlich Adaptimmune Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-119 M | -85 M | -126 M | -37.8 M | -11.3 M | 68.4 M | 40.2 M | -159 M | -186 M | -51.3 M | 1.29 M | -3.02 M | - |
Langfristige Schulden |
19.9 M | 20.3 M | 23.1 M | 20.9 M | 23 M | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
5.38 M | 2.73 M | 2.32 M | 2.77 M | 2.49 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 23.6 M | 5.41 M | 3.85 M | 28.1 M | 11.6 M | - | - | - | - |
Kurzfristige Verbindlichkeiten |
72.8 M | 64.5 M | 62.5 M | 39.1 M | 34.3 M | 24.4 M | 74.3 M | 40.3 M | 27.9 M | - | - | - | - |
Gesamtverbindlichkeiten |
243 M | 247 M | 264 M | 110 M | 57.9 M | 29.9 M | 78.2 M | 68.4 M | 33.4 M | 53.1 M | 3.97 M | 4.09 M | - |
Aufgeschobenes Einkommen |
29 M | 23.5 M | 22.2 M | 2.83 M | 2.13 M | - | 38.7 M | 11.4 M | - | - | - | - | - |
Gewinnrücklagen |
-1.02 B | -909 M | -744 M | -586 M | -456 M | -318 M | -232 M | -161 M | -38.3 M | -32.3 M | -17.6 M | -9.66 M | - |
Vermögenswerte |
283 M | 329 M | 470 M | 451 M | 182 M | 277 M | 281 M | 235 M | 244 M | 55.5 M | 1.81 M | 3.96 M | - |
Zahlungsmittel |
144 M | 108 M | 152 M | 61.5 M | 50.4 M | 68.4 M | 84 M | 159 M | 194 M | - | - | - | - |
Buchwert |
39.5 M | 81.9 M | 206 M | 341 M | 124 M | 247 M | 203 M | 166 M | 211 M | 2.41 M | -2.16 M | -126 K | - |
Gesamtes Eigenkapital |
39.5 M | 81.9 M | 206 M | 341 M | 124 M | 247 M | 203 M | 166 M | 235 M | 2.96 M | -2.16 M | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Adaptimmune Therapeutics plc
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
18.4 M | 19.9 M | 20.5 M | 21.6 M | 20 M | 20.3 M | 19.9 M | - | 23.2 M | 23.1 M | 23.7 M | 19.7 M | 19.9 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 23 M | 23 M | 23 M | 23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
234 M | 243 M | 209 M | 216 M | 204 M | 247 M | 219 M | - | 257 M | 264 M | 113 M | 112 M | 102 M | 110 M | 110 M | 110 M | 110 M | 57.9 M | 57.9 M | 57.9 M | 57.9 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 68.4 M | 68.4 M | 68.4 M | 42.6 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | - | - | 52.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
31.5 M | 29 M | 29.3 M | 31.4 M | 22.3 M | 23.5 M | 20.6 M | - | 24.8 M | 22.2 M | 6.1 M | 4.91 M | 2.08 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 2.13 M | 2.13 M | 2.13 M | 2.13 M | - | 1.34 M | 16.7 M | 27.2 M | 38.7 M | 42.6 M | 12.3 M | 11.6 M | 11.4 M | 11.4 M | 11.4 M | 12.1 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | - | - | 41.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-1.07 B | -1.02 B | -975 M | -930 M | -908 M | -909 M | -880 M | - | -794 M | -744 M | -705 M | -663 M | -624 M | -586 M | -586 M | -586 M | -586 M | -456 M | -456 M | -456 M | -456 M | -318 M | -318 M | -318 M | -318 M | -232 M | -232 M | -232 M | -232 M | -161 M | -161 M | -161 M | -105 M | -89.9 M | -89.9 M | -89.9 M | -89.9 M | - | - | -30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
258 M | 283 M | 297 M | 343 M | 288 M | 329 M | 332 M | - | 420 M | 470 M | 354 M | 390 M | 412 M | 451 M | 451 M | 451 M | 451 M | 182 M | 182 M | 182 M | 182 M | 277 M | 277 M | 277 M | 277 M | 281 M | 281 M | 281 M | 281 M | 235 M | 235 M | 235 M | 262 M | 286 M | 286 M | 286 M | 286 M | - | - | 55.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
141 M | 144 M | 90.1 M | 77 M | 121 M | 108 M | 80.7 M | 99.5 M | 91.3 M | 150 M | 44.6 M | 50.5 M | 32.4 M | 56.9 M | 56.9 M | 56.9 M | 56.9 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 68.4 M | 68.4 M | 68.4 M | 68.4 M | 84 M | 84 M | 84 M | 84 M | 159 M | 159 M | 159 M | 164 M | 194 M | 194 M | 194 M | 194 M | 102 M | - | 51.2 M | - | - | - | - | - | - | - | 3.11 M | - | - | - | - | - |
Buchwert |
24.4 M | 39.5 M | 88.1 M | 127 M | 83.9 M | 81.9 M | 113 M | - | 163 M | 206 M | 241 M | 278 M | 309 M | 341 M | 341 M | 341 M | 341 M | 124 M | 124 M | 124 M | 124 M | 247 M | 247 M | 247 M | 247 M | 203 M | 203 M | 203 M | 203 M | 166 M | 166 M | 166 M | 219 M | 235 M | 235 M | 235 M | 235 M | - | - | 2.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
24.4 M | 39.5 M | 88.1 M | 127 M | 83.9 M | 81.9 M | 113 M | 142 M | 163 M | 206 M | 241 M | 278 M | 309 M | 341 M | 341 M | 341 M | 341 M | 124 M | 124 M | 124 M | 124 M | 247 M | 276 M | 247 M | 247 M | 203 M | 229 M | 229 M | 208 M | 166 M | 166 M | 166 M | 219 M | 235 M | 235 M | 235 M | 235 M | - | - | 2.96 M | - | - | - | -2.16 M | - | - | - | -124 K | - | - | - | - | - |
Alle Zahlen in USD-Währung